Current investigations for liver fibrosis treatment: between repurposing the FDA-approved drugs and the other emerging approaches

Long-term liver injuries lead to hepatic fibrosis, often progressing into cirrhosis, liver failure, portal hypertension, and hepatocellular carcinoma. There is currently no effective therapy available for liver fibrosis. Thus, continuous investigations for anti-fibrotic therapy are ongoing. The main...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Omima S. Mohammed, Hany G. Attia, Bassim M. S. A. Mohamed, Marawan A. Elbaset, Hany M. Fayed
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2023-11-01
Serier:	Journal of Pharmacy & Pharmaceutical Sciences
Fag:	liver fibrosis anti-fibrotic agents HSCs therapeutic targets pharmacotherapy
Online adgang:	https://www.frontierspartnerships.org/articles/10.3389/jpps.2023.11808/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!